SCHEMBL17437386

SCHEMBL17437386

Nc1ncnn1-c1nc2cnccc2n1-c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA5 O75582 5/20 0.49
▸ ALDH1A1 P00352 5/20 0.43
▸ FGFR1 P11362 1/20 0.43
▸ ATM Q13315 1/20 0.38
▸ CYP1A2 P05177 4/20 0.37
▸ CYP2C9 P11712 4/20 0.37
▸ CYP3A4 P08684 3/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ USP2 O75604 3/20 0.36
▸ CYP2C19 P33261 3/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ AOC3 Q16853 1/20 0.36
▸ CYP2D6 P10635 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437439 0.81 RPS6KA5 (0.45) RPS6KA5ALDH1A1FGFR1ATMHSD17B10
SCHEMBL17437535 0.81 BRD4 (0.43) RPS6KA5ALDH1A1CYP1A2CYP2C9CYP3A4
SCHEMBL17437518 0.81 RPS6KA5 (0.50) RPS6KA5ALDH1A1FGFR1ATMMAPK1
SCHEMBL17437328 0.79 CYP1A2 (0.35) RPS6KA5ALDH1A1CYP1A2CYP2C9CYP3A4
SCHEMBL17437495 0.79 HTR3A (0.41) RPS6KA5ATMCYP1A2CYP2C9CYP3A4
SCHEMBL17437574 0.79 RPS6KA5 (0.48) RPS6KA5ALDH1A1FGFR1ATMMAPK1
SCHEMBL17437416 0.79 RPS6KA5 (0.51) RPS6KA5ALDH1A1FGFR1ATMMAPK1
SCHEMBL17437510 0.78 RPS6KA5 (0.47) RPS6KA5ALDH1A1FGFR1ATMHSD17B10
SCHEMBL17437357 0.77 RPS6KA5 (0.46) RPS6KA5ALDH1A1FGFR1ATMMAPK1
SCHEMBL17437317 0.76 ALDH1A1 (0.33) ALDH1A1CYP1A2CYP2C9CYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 RPS6KA5 2731/4885ALDH1A1 928/4885FGFR1 2477/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 RPS6KA5 2731/4885ALDH1A1 928/4885FGFR1 2477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback